Fernando Guerrero-Romero, Oliver Micke, Luis E. Simental-Mendía, Martha Rodríguez-Morán, Juergen Vormann, Stefano Iotti, Nikolina Banjanin, Andrea Rosanoff, Shadi Baniasadi, Guitti Pourdowlat and Mihai Nechifor

Biology, 2023, 12, 735
DOI: 10.3390/biology12050735

Noncognate HER2 sensitivity to cognate EGFR allosteric inhibitors at molecular level: New uses for old drugs in gynecological tumors

Xin He, Ye Hao, Xiaoyan Liu, Jing Guan and Li Wang

J Chinese Chemical Soc, 2022, 69, 388
DOI: 10.1002/jccs.202100489

Systematic analysis and comparison of peptide specificity and selectivity between their cognate receptors and noncognate decoys

Jianping Shu, Juelin Li, Shaozhou Wang, Jing Lin, Li Wen, Haiyang Ye and Peng Zhou

J of Molecular Recognition, 2023, 36
DOI: 10.1002/jmr.3006

Targeting peptide‐mediated interactions in omics

Jing Lin, Shaozhou Wang, Li Wen, Haiyang Ye, Shuyong Shang, Juelin Li, Jianping Shu and Peng Zhou

Proteomics, 2023, 23
DOI: 10.1002/pmic.202200175

Rational molecular design of novel class-III peptidic antagonists to competitively disrupt human PPARδ self-binding peptide

Yue Peng, Zilong Li, Yunyi Zhang, Haiyang Ye, Li Mei, Shuyong Shang and Peng Zhou

J Comput Aided Mol Des, 2025, 39
DOI: 10.1007/s10822-025-00594-4

Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy

Hai Zhong, Jiajia He, Jingjing Yu, Xiang Li, Yuxian Mei, Long Hao and Xu Wu

Biochimie, 2021, 190, 132
DOI: 10.1016/j.biochi.2021.07.002

Rational truncation, mutation, and halogenation of bradykinin neuropeptides as potent ACEII inhibitors by integrating molecular dynamics simulations, quantum mechanics calculations, and in vitro assays

Jun Fu, Shenghui Chen and Zhong Ni

J Chinese Chemical Soc, 2022, 69, 1569
DOI: 10.1002/jccs.202200242

Facilitating the drug repurposing with iC/E strategy: A practice on novel nNOS inhibitor discovery

Zhaoyang Hu, Qingsen Liu and Zhong Ni

J. Bioinform. Comput. Biol., 2023, 21
DOI: 10.1142/S021972002350018X

Molecular insight into the π‐stacking interactions of human ovarian cancer PARP‐1 with its small‐molecule inhibitors and rational design of aromatic amino acid‐rich peptides to target PARP‐1 based on the π‐stacking network

Chunxia Pan, Lei Chen, Xinxin Zhang, Depu Zhang, Quqing Song, Jingwei Peng and Qingshui Li

J Chinese Chemical Soc, 2022, 69, 775
DOI: 10.1002/jccs.202200004

Interleukin‐1α, interleukin‐1β and interleukin‐1 receptor antagonist share a common U‐shaped recognition epitope on interleukin‐1 receptor surface

Huaijun Ma, Jie Liu, Wei Wu and Ping He

J of Molecular Recognition, 2022, 35
DOI: 10.1002/jmr.2963

Computational Analysis and Molecular Design of Aromatic Stacking System Between Human ARTD2 Catalytic Domain and its Small-Molecule Inhibitors and Peptidic Ligands

Rui Liu and Lijun Liu

J. Comput. Biophys. Chem., 2022, 21, 529
DOI: 10.1142/S2737416522500181

The binding affinity of human pediatric respiratory syncytial virus Phosphoprotein's C-terminal tail to nucleocapsid can be improved by a rationally designed halogen-bonded system

Yaqi Xue, Xiangxiang Shi, Dengmei Feng and Yunhong Wang

Journal of Molecular Graphics and Modelling, 2023, 118, 108374
DOI: 10.1016/j.jmgm.2022.108374

Computational design and experimental confirmation of conformationally constrained peptides to compete with coactivators for pediatric PPARα by minimizing indirect readout effect

Caijie Gao, Xu Zhao and Jianrong Fan

J. Bioinform. Comput. Biol., 2022, 20
DOI: 10.1142/S0219720022500202

Integratedin silico–in vitrorational design of oncogenic EGFR-derived specific monoclonal antibody-binding peptide mimotopes

Ke Chen, Lili Ge and Guorui Liu

J. Bioinform. Comput. Biol., 2023, 21
DOI: 10.1142/S0219720023500075

Molecular conversion of MIG6 hotspot-3 peptide from the nonbinder to a moderate binder of HER2 by rational design of an orthogonal interaction system at the HER2–peptide interface

Aihong Zhang, Ping Liu, Chuncheng Dou, Yao Liu and Lifan Che

Biophysical Chemistry, 2021, 276, 106625
DOI: 10.1016/j.bpc.2021.106625

Exploiting the chemical diversity space of phosphopeptide binding to nasopharyngeal carcinoma PLK1 PBD domain with unnatural amino acid building blocks by using QSAR-based genetic optimization

R.Y. Ma, J. Yang, J.J. Wu and H.Y. Zhu

SAR and QSAR in Environmental Research, 2024, 35, 899
DOI: 10.1080/1062936X.2024.2418355

Use of Apatinib as a Bait to Fish its Unexpected Kinase Targets from the Hepatocellular Carcinoma Druggable Kinome

Rui Liu and Lijun Liu

J. Comput. Biophys. Chem., 2023, 22, 439
DOI: 10.1142/S2737416523500187

Comprehensive binary interaction mapping of τ phosphotyrosine sites with SH2 domains in the human genome: Implications for the rational design of self-inhibitory phosphopeptides to target τ hyperphosphorylation signaling in Alzheimer’s Disease

Zhonglei Bao, Jianghua Liu and Jin Fu

Amino Acids, 2022, 54, 859
DOI: 10.1007/s00726-022-03171-3

The Binding Behavior of Peptide Ligands to Human Osteoclast-Stimulating Factor SH3 Domain Shifted by a Rationally Designed π-Stacking System

Qi Huang, Xianquan Xu, Xiaoting Song and Dun Hong

J. Comput. Biophys. Chem., 2023, 22, 1
DOI: 10.1142/S2737416522500430

Molecular analysis and systematic profiling of allosteric inhibitor response to clinically significant epidermal growth factor receptor missense mutations in non‐small cell lung cancer

Yan Zhao, Dan Zhu and Junzhen Gao

J Chinese Chemical Soc, 2021, 68, 2021
DOI: 10.1002/jccs.202100217

Scaffold-based analysis of nonpeptide oncogenic FTase inhibitors using multiple similarity matching, binding affinity scoring and enzyme inhibition assay

Qifei Wang, Fei Chen, Peng Liu, Yushu Mu, Shibin Sun, Xulong Yuan, Pan Shang and Bo Ji

Journal of Molecular Graphics and Modelling, 2021, 105, 107898
DOI: 10.1016/j.jmgm.2021.107898